Effect of Body Mass Index on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation

Better outcomes have been reported after percutaneous cardiac intervention in obese patients (“obesity paradox”). However, limited information is available on the effect of the body mass index on the outcomes after transcatheter aortic valve implantation (TAVI). We, therefore, sought to determine th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2013-01, Vol.111 (2), p.231-236
Hauptverfasser: van der Boon, Robert M.A., MSc, Chieffo, Alaide, MD, Dumonteil, Nicolas, MD, Tchetche, Didier, MD, Van Mieghem, Nicolas M., MD, Buchanan, Gill L., MBChB, Vahdat, Olivier, MD, Marcheix, Bertrand, MD, PhD, Serruys, Patrick W., MD, PhD, Fajadet, Jean, MD, Colombo, Antonio, MD, PhD, Carrié, Didier, MD, PhD, van Domburg, Ron T., PhD, de Jaegere, Peter P.T., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 236
container_issue 2
container_start_page 231
container_title The American journal of cardiology
container_volume 111
creator van der Boon, Robert M.A., MSc
Chieffo, Alaide, MD
Dumonteil, Nicolas, MD
Tchetche, Didier, MD
Van Mieghem, Nicolas M., MD
Buchanan, Gill L., MBChB
Vahdat, Olivier, MD
Marcheix, Bertrand, MD, PhD
Serruys, Patrick W., MD, PhD
Fajadet, Jean, MD
Colombo, Antonio, MD, PhD
Carrié, Didier, MD, PhD
van Domburg, Ron T., PhD
de Jaegere, Peter P.T., MD, PhD
description Better outcomes have been reported after percutaneous cardiac intervention in obese patients (“obesity paradox”). However, limited information is available on the effect of the body mass index on the outcomes after transcatheter aortic valve implantation (TAVI). We, therefore, sought to determine the effect of the body mass index on the short- and long-term outcomes in patients who underwent TAVI. The population consisted of 940 patients, of whom 25 (2.7%) were underweight, 384 had a (40.9%) normal weight, 372 (39.6%) were overweight, and 159 (16.9%) were obese. Overall, the obese patients were younger (79.7 ± 6.4 years vs 81.7 ± 7.3 and 80.8 ± 7.0 years, p = 0.008) and had a greater prevalence of preserved left ventricular and renal function. On univariate analysis, obese patients had a greater incidence of minor stroke (1.3% vs 0 and 0.3%, p = 0.03), minor vascular complications (15.7% vs 9.1% and 11.6%, p = 0.028) and acute kidney injury stage I (23.3% vs 10.7% and 16.1%, p
doi_str_mv 10.1016/j.amjcard.2012.09.022
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273253991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000291491202200X</els_id><sourcerecordid>2855443541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c561t-e67232680c028cf6d0f0f9c0567e6e996064ed6568aa2d343f51dee4657d30963</originalsourceid><addsrcrecordid>eNqFkk-P0zAQxS0EYkvhI4AsceGS4D-JU19AZbXsVirawxbEzTL2mDokcbGTFf32OGoBaS-crJF-bzzz3iD0kpKSEiretqXuW6OjLRmhrCSyJIw9Qgu6amRBJeWP0YIQwgpJK3mBnqXU5pLSWjxFF4xTwjK4QPsr58CMODj8Idgj_qRTwpvBwi8cBny3D3EssB4s3obhe7GD2OPbaTShh4TXboSId1EPyehxD3O1zgJv8Bfd3QPe9IdOD6MefRieoydOdwlenN8l-vzxand5U2xvrzeX621hakHHAkTDOBMrYvKAxglLHHHSkFo0IEBKQUQFVtRipTWzvOKuphagEnVjOZGCL9GbU99DDD8nSKPqfTLQ5UEgTElR1nBWc5kdWqLXD9A2THHI02VKCCJZRVmm6hNlYkgpglOH6Hsdj4oSNUehWnWOQs1RKCJVjiLrXp27T996sH9Vf7zPwPsTANmOew9RJeNhMGB9zJEoG_x_v3j3oIPp_OCN7n7AEdK_bVTKGnU338N8DpRlNSFf-W-ZBq-C</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1266092412</pqid></control><display><type>article</type><title>Effect of Body Mass Index on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>van der Boon, Robert M.A., MSc ; Chieffo, Alaide, MD ; Dumonteil, Nicolas, MD ; Tchetche, Didier, MD ; Van Mieghem, Nicolas M., MD ; Buchanan, Gill L., MBChB ; Vahdat, Olivier, MD ; Marcheix, Bertrand, MD, PhD ; Serruys, Patrick W., MD, PhD ; Fajadet, Jean, MD ; Colombo, Antonio, MD, PhD ; Carrié, Didier, MD, PhD ; van Domburg, Ron T., PhD ; de Jaegere, Peter P.T., MD, PhD</creator><creatorcontrib>van der Boon, Robert M.A., MSc ; Chieffo, Alaide, MD ; Dumonteil, Nicolas, MD ; Tchetche, Didier, MD ; Van Mieghem, Nicolas M., MD ; Buchanan, Gill L., MBChB ; Vahdat, Olivier, MD ; Marcheix, Bertrand, MD, PhD ; Serruys, Patrick W., MD, PhD ; Fajadet, Jean, MD ; Colombo, Antonio, MD, PhD ; Carrié, Didier, MD, PhD ; van Domburg, Ron T., PhD ; de Jaegere, Peter P.T., MD, PhD ; PRAGMATIC-Plus Researchers</creatorcontrib><description>Better outcomes have been reported after percutaneous cardiac intervention in obese patients (“obesity paradox”). However, limited information is available on the effect of the body mass index on the outcomes after transcatheter aortic valve implantation (TAVI). We, therefore, sought to determine the effect of the body mass index on the short- and long-term outcomes in patients who underwent TAVI. The population consisted of 940 patients, of whom 25 (2.7%) were underweight, 384 had a (40.9%) normal weight, 372 (39.6%) were overweight, and 159 (16.9%) were obese. Overall, the obese patients were younger (79.7 ± 6.4 years vs 81.7 ± 7.3 and 80.8 ± 7.0 years, p = 0.008) and had a greater prevalence of preserved left ventricular and renal function. On univariate analysis, obese patients had a greater incidence of minor stroke (1.3% vs 0 and 0.3%, p = 0.03), minor vascular complications (15.7% vs 9.1% and 11.6%, p = 0.028) and acute kidney injury stage I (23.3% vs 10.7% and 16.1%, p &lt;0.001). After adjustment, body mass index, as a continuous variable, was associated with a lower risk of mortality at 30 days (odds ratio 0.93, 95% confidence interval 0.86 to 0.98, p = 0.023) and no effect on survival after discharge (hazard ratio 1.01, 95% confidence interval 0.96 to 1.07, p = 0.73). In conclusion, obesity was associated with a greater incidence of minor, but no major, perioperative complications after TAVI. After adjustment, obesity was associated with a lower risk of 30-day mortality and had no adverse effect on mortality after discharge, underscoring the “obesity paradox” in patients undergoing TAVI.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2012.09.022</identifier><identifier>PMID: 23102879</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aortic Valve ; Aortic Valve Stenosis - complications ; Aortic Valve Stenosis - mortality ; Aortic Valve Stenosis - surgery ; Body Mass Index ; Cardiac Catheterization - methods ; Cardiovascular ; Cardiovascular disease ; Drug therapy ; Europe - epidemiology ; Follow-Up Studies ; Heart attacks ; Heart Valve Prosthesis ; Hospital Mortality - trends ; Humans ; Kaplan-Meier Estimate ; Length of Stay ; Mortality ; Obesity ; Obesity - complications ; Obesity - mortality ; Odds Ratio ; Postoperative Period ; Risk Assessment - methods ; Risk Factors ; Time Factors ; Treatment Outcome</subject><ispartof>The American journal of cardiology, 2013-01, Vol.111 (2), p.231-236</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c561t-e67232680c028cf6d0f0f9c0567e6e996064ed6568aa2d343f51dee4657d30963</citedby><cites>FETCH-LOGICAL-c561t-e67232680c028cf6d0f0f9c0567e6e996064ed6568aa2d343f51dee4657d30963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S000291491202200X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23102879$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van der Boon, Robert M.A., MSc</creatorcontrib><creatorcontrib>Chieffo, Alaide, MD</creatorcontrib><creatorcontrib>Dumonteil, Nicolas, MD</creatorcontrib><creatorcontrib>Tchetche, Didier, MD</creatorcontrib><creatorcontrib>Van Mieghem, Nicolas M., MD</creatorcontrib><creatorcontrib>Buchanan, Gill L., MBChB</creatorcontrib><creatorcontrib>Vahdat, Olivier, MD</creatorcontrib><creatorcontrib>Marcheix, Bertrand, MD, PhD</creatorcontrib><creatorcontrib>Serruys, Patrick W., MD, PhD</creatorcontrib><creatorcontrib>Fajadet, Jean, MD</creatorcontrib><creatorcontrib>Colombo, Antonio, MD, PhD</creatorcontrib><creatorcontrib>Carrié, Didier, MD, PhD</creatorcontrib><creatorcontrib>van Domburg, Ron T., PhD</creatorcontrib><creatorcontrib>de Jaegere, Peter P.T., MD, PhD</creatorcontrib><creatorcontrib>PRAGMATIC-Plus Researchers</creatorcontrib><title>Effect of Body Mass Index on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Better outcomes have been reported after percutaneous cardiac intervention in obese patients (“obesity paradox”). However, limited information is available on the effect of the body mass index on the outcomes after transcatheter aortic valve implantation (TAVI). We, therefore, sought to determine the effect of the body mass index on the short- and long-term outcomes in patients who underwent TAVI. The population consisted of 940 patients, of whom 25 (2.7%) were underweight, 384 had a (40.9%) normal weight, 372 (39.6%) were overweight, and 159 (16.9%) were obese. Overall, the obese patients were younger (79.7 ± 6.4 years vs 81.7 ± 7.3 and 80.8 ± 7.0 years, p = 0.008) and had a greater prevalence of preserved left ventricular and renal function. On univariate analysis, obese patients had a greater incidence of minor stroke (1.3% vs 0 and 0.3%, p = 0.03), minor vascular complications (15.7% vs 9.1% and 11.6%, p = 0.028) and acute kidney injury stage I (23.3% vs 10.7% and 16.1%, p &lt;0.001). After adjustment, body mass index, as a continuous variable, was associated with a lower risk of mortality at 30 days (odds ratio 0.93, 95% confidence interval 0.86 to 0.98, p = 0.023) and no effect on survival after discharge (hazard ratio 1.01, 95% confidence interval 0.96 to 1.07, p = 0.73). In conclusion, obesity was associated with a greater incidence of minor, but no major, perioperative complications after TAVI. After adjustment, obesity was associated with a lower risk of 30-day mortality and had no adverse effect on mortality after discharge, underscoring the “obesity paradox” in patients undergoing TAVI.</description><subject>Aortic Valve</subject><subject>Aortic Valve Stenosis - complications</subject><subject>Aortic Valve Stenosis - mortality</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Body Mass Index</subject><subject>Cardiac Catheterization - methods</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Drug therapy</subject><subject>Europe - epidemiology</subject><subject>Follow-Up Studies</subject><subject>Heart attacks</subject><subject>Heart Valve Prosthesis</subject><subject>Hospital Mortality - trends</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Length of Stay</subject><subject>Mortality</subject><subject>Obesity</subject><subject>Obesity - complications</subject><subject>Obesity - mortality</subject><subject>Odds Ratio</subject><subject>Postoperative Period</subject><subject>Risk Assessment - methods</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkk-P0zAQxS0EYkvhI4AsceGS4D-JU19AZbXsVirawxbEzTL2mDokcbGTFf32OGoBaS-crJF-bzzz3iD0kpKSEiretqXuW6OjLRmhrCSyJIw9Qgu6amRBJeWP0YIQwgpJK3mBnqXU5pLSWjxFF4xTwjK4QPsr58CMODj8Idgj_qRTwpvBwi8cBny3D3EssB4s3obhe7GD2OPbaTShh4TXboSId1EPyehxD3O1zgJv8Bfd3QPe9IdOD6MefRieoydOdwlenN8l-vzxand5U2xvrzeX621hakHHAkTDOBMrYvKAxglLHHHSkFo0IEBKQUQFVtRipTWzvOKuphagEnVjOZGCL9GbU99DDD8nSKPqfTLQ5UEgTElR1nBWc5kdWqLXD9A2THHI02VKCCJZRVmm6hNlYkgpglOH6Hsdj4oSNUehWnWOQs1RKCJVjiLrXp27T996sH9Vf7zPwPsTANmOew9RJeNhMGB9zJEoG_x_v3j3oIPp_OCN7n7AEdK_bVTKGnU338N8DpRlNSFf-W-ZBq-C</recordid><startdate>20130115</startdate><enddate>20130115</enddate><creator>van der Boon, Robert M.A., MSc</creator><creator>Chieffo, Alaide, MD</creator><creator>Dumonteil, Nicolas, MD</creator><creator>Tchetche, Didier, MD</creator><creator>Van Mieghem, Nicolas M., MD</creator><creator>Buchanan, Gill L., MBChB</creator><creator>Vahdat, Olivier, MD</creator><creator>Marcheix, Bertrand, MD, PhD</creator><creator>Serruys, Patrick W., MD, PhD</creator><creator>Fajadet, Jean, MD</creator><creator>Colombo, Antonio, MD, PhD</creator><creator>Carrié, Didier, MD, PhD</creator><creator>van Domburg, Ron T., PhD</creator><creator>de Jaegere, Peter P.T., MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20130115</creationdate><title>Effect of Body Mass Index on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation</title><author>van der Boon, Robert M.A., MSc ; Chieffo, Alaide, MD ; Dumonteil, Nicolas, MD ; Tchetche, Didier, MD ; Van Mieghem, Nicolas M., MD ; Buchanan, Gill L., MBChB ; Vahdat, Olivier, MD ; Marcheix, Bertrand, MD, PhD ; Serruys, Patrick W., MD, PhD ; Fajadet, Jean, MD ; Colombo, Antonio, MD, PhD ; Carrié, Didier, MD, PhD ; van Domburg, Ron T., PhD ; de Jaegere, Peter P.T., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c561t-e67232680c028cf6d0f0f9c0567e6e996064ed6568aa2d343f51dee4657d30963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aortic Valve</topic><topic>Aortic Valve Stenosis - complications</topic><topic>Aortic Valve Stenosis - mortality</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Body Mass Index</topic><topic>Cardiac Catheterization - methods</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Drug therapy</topic><topic>Europe - epidemiology</topic><topic>Follow-Up Studies</topic><topic>Heart attacks</topic><topic>Heart Valve Prosthesis</topic><topic>Hospital Mortality - trends</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Length of Stay</topic><topic>Mortality</topic><topic>Obesity</topic><topic>Obesity - complications</topic><topic>Obesity - mortality</topic><topic>Odds Ratio</topic><topic>Postoperative Period</topic><topic>Risk Assessment - methods</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van der Boon, Robert M.A., MSc</creatorcontrib><creatorcontrib>Chieffo, Alaide, MD</creatorcontrib><creatorcontrib>Dumonteil, Nicolas, MD</creatorcontrib><creatorcontrib>Tchetche, Didier, MD</creatorcontrib><creatorcontrib>Van Mieghem, Nicolas M., MD</creatorcontrib><creatorcontrib>Buchanan, Gill L., MBChB</creatorcontrib><creatorcontrib>Vahdat, Olivier, MD</creatorcontrib><creatorcontrib>Marcheix, Bertrand, MD, PhD</creatorcontrib><creatorcontrib>Serruys, Patrick W., MD, PhD</creatorcontrib><creatorcontrib>Fajadet, Jean, MD</creatorcontrib><creatorcontrib>Colombo, Antonio, MD, PhD</creatorcontrib><creatorcontrib>Carrié, Didier, MD, PhD</creatorcontrib><creatorcontrib>van Domburg, Ron T., PhD</creatorcontrib><creatorcontrib>de Jaegere, Peter P.T., MD, PhD</creatorcontrib><creatorcontrib>PRAGMATIC-Plus Researchers</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van der Boon, Robert M.A., MSc</au><au>Chieffo, Alaide, MD</au><au>Dumonteil, Nicolas, MD</au><au>Tchetche, Didier, MD</au><au>Van Mieghem, Nicolas M., MD</au><au>Buchanan, Gill L., MBChB</au><au>Vahdat, Olivier, MD</au><au>Marcheix, Bertrand, MD, PhD</au><au>Serruys, Patrick W., MD, PhD</au><au>Fajadet, Jean, MD</au><au>Colombo, Antonio, MD, PhD</au><au>Carrié, Didier, MD, PhD</au><au>van Domburg, Ron T., PhD</au><au>de Jaegere, Peter P.T., MD, PhD</au><aucorp>PRAGMATIC-Plus Researchers</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Body Mass Index on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2013-01-15</date><risdate>2013</risdate><volume>111</volume><issue>2</issue><spage>231</spage><epage>236</epage><pages>231-236</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Better outcomes have been reported after percutaneous cardiac intervention in obese patients (“obesity paradox”). However, limited information is available on the effect of the body mass index on the outcomes after transcatheter aortic valve implantation (TAVI). We, therefore, sought to determine the effect of the body mass index on the short- and long-term outcomes in patients who underwent TAVI. The population consisted of 940 patients, of whom 25 (2.7%) were underweight, 384 had a (40.9%) normal weight, 372 (39.6%) were overweight, and 159 (16.9%) were obese. Overall, the obese patients were younger (79.7 ± 6.4 years vs 81.7 ± 7.3 and 80.8 ± 7.0 years, p = 0.008) and had a greater prevalence of preserved left ventricular and renal function. On univariate analysis, obese patients had a greater incidence of minor stroke (1.3% vs 0 and 0.3%, p = 0.03), minor vascular complications (15.7% vs 9.1% and 11.6%, p = 0.028) and acute kidney injury stage I (23.3% vs 10.7% and 16.1%, p &lt;0.001). After adjustment, body mass index, as a continuous variable, was associated with a lower risk of mortality at 30 days (odds ratio 0.93, 95% confidence interval 0.86 to 0.98, p = 0.023) and no effect on survival after discharge (hazard ratio 1.01, 95% confidence interval 0.96 to 1.07, p = 0.73). In conclusion, obesity was associated with a greater incidence of minor, but no major, perioperative complications after TAVI. After adjustment, obesity was associated with a lower risk of 30-day mortality and had no adverse effect on mortality after discharge, underscoring the “obesity paradox” in patients undergoing TAVI.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23102879</pmid><doi>10.1016/j.amjcard.2012.09.022</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2013-01, Vol.111 (2), p.231-236
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_1273253991
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Aortic Valve
Aortic Valve Stenosis - complications
Aortic Valve Stenosis - mortality
Aortic Valve Stenosis - surgery
Body Mass Index
Cardiac Catheterization - methods
Cardiovascular
Cardiovascular disease
Drug therapy
Europe - epidemiology
Follow-Up Studies
Heart attacks
Heart Valve Prosthesis
Hospital Mortality - trends
Humans
Kaplan-Meier Estimate
Length of Stay
Mortality
Obesity
Obesity - complications
Obesity - mortality
Odds Ratio
Postoperative Period
Risk Assessment - methods
Risk Factors
Time Factors
Treatment Outcome
title Effect of Body Mass Index on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T21%3A44%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Body%20Mass%20Index%20on%20Short-%20and%20Long-Term%20Outcomes%20After%20Transcatheter%20Aortic%20Valve%20Implantation&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=van%20der%20Boon,%20Robert%20M.A.,%20MSc&rft.aucorp=PRAGMATIC-Plus%20Researchers&rft.date=2013-01-15&rft.volume=111&rft.issue=2&rft.spage=231&rft.epage=236&rft.pages=231-236&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2012.09.022&rft_dat=%3Cproquest_cross%3E2855443541%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1266092412&rft_id=info:pmid/23102879&rft_els_id=S000291491202200X&rfr_iscdi=true